TY - JOUR
T1 - The Tyrosine Phosphatase STEP Is Involved in Age-Related Memory Decline
AU - Castonguay, David
AU - Dufort-Gervais, Julien
AU - Ménard, Caroline
AU - Chatterjee, Manavi
AU - Quirion, Rémi
AU - Bontempi, Bruno
AU - Schneider, Jay S.
AU - Arnsten, Amy F.T.
AU - Nairn, Angus C.
AU - Norris, Christopher M.
AU - Ferland, Guylaine
AU - Bézard, Erwan
AU - Gaudreau, Pierrette
AU - Lombroso, Paul J.
AU - Brouillette, Jonathan
N1 - Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/4/2
Y1 - 2018/4/2
N2 - Cognitive disabilities that occur with age represent a growing and expensive health problem. Age-associated memory deficits are observed across many species, but the underlying molecular mechanisms remain to be fully identified. Here, we report elevations in the levels and activity of the striatal-enriched phosphatase (STEP) in the hippocampus of aged memory-impaired mice and rats, in aged rhesus monkeys, and in people diagnosed with amnestic mild cognitive impairment (aMCI). The accumulation of STEP with aging is related to dysfunction of the ubiquitin-proteasome system that normally leads to the degradation of STEP. Higher level of active STEP is linked to enhanced dephosphorylation of its substrates GluN2B and ERK1/2, CREB inactivation, and a decrease in total levels of GluN2B and brain-derived neurotrophic factor (BDNF). These molecular events are reversed in aged STEP knockout and heterozygous mice, which perform similarly to young control mice in the Morris water maze (MWM) and Y-maze tasks. In addition, administration of the STEP inhibitor TC-2153 to old rats significantly improved performance in a delayed alternation T-maze memory task. In contrast, viral-mediated STEP overexpression in the hippocampus is sufficient to induce memory impairment in the MWM and Y-maze tests, and these cognitive deficits are reversed by STEP inhibition. In old LOU/C/Jall rats, a model of healthy aging with preserved memory capacities, levels of STEP and GluN2B are stable, and phosphorylation of GluN2B and ERK1/2 is unaltered. Altogether, these data suggest that elevated levels of STEP that appear with advancing age in several species contribute to the cognitive declines associated with aging. The molecular changes leading to memory deficits during aging remain to be fully identified. Castonguay et al. provide genetic, behavioral, and molecular evidence that accumulation of the phosphatase STEP is a common molecular event that oppose synaptic strengthening and contributes to age-related memory deficits in mice, rats, monkeys, and humans.
AB - Cognitive disabilities that occur with age represent a growing and expensive health problem. Age-associated memory deficits are observed across many species, but the underlying molecular mechanisms remain to be fully identified. Here, we report elevations in the levels and activity of the striatal-enriched phosphatase (STEP) in the hippocampus of aged memory-impaired mice and rats, in aged rhesus monkeys, and in people diagnosed with amnestic mild cognitive impairment (aMCI). The accumulation of STEP with aging is related to dysfunction of the ubiquitin-proteasome system that normally leads to the degradation of STEP. Higher level of active STEP is linked to enhanced dephosphorylation of its substrates GluN2B and ERK1/2, CREB inactivation, and a decrease in total levels of GluN2B and brain-derived neurotrophic factor (BDNF). These molecular events are reversed in aged STEP knockout and heterozygous mice, which perform similarly to young control mice in the Morris water maze (MWM) and Y-maze tasks. In addition, administration of the STEP inhibitor TC-2153 to old rats significantly improved performance in a delayed alternation T-maze memory task. In contrast, viral-mediated STEP overexpression in the hippocampus is sufficient to induce memory impairment in the MWM and Y-maze tests, and these cognitive deficits are reversed by STEP inhibition. In old LOU/C/Jall rats, a model of healthy aging with preserved memory capacities, levels of STEP and GluN2B are stable, and phosphorylation of GluN2B and ERK1/2 is unaltered. Altogether, these data suggest that elevated levels of STEP that appear with advancing age in several species contribute to the cognitive declines associated with aging. The molecular changes leading to memory deficits during aging remain to be fully identified. Castonguay et al. provide genetic, behavioral, and molecular evidence that accumulation of the phosphatase STEP is a common molecular event that oppose synaptic strengthening and contributes to age-related memory deficits in mice, rats, monkeys, and humans.
KW - aging
KW - animal behaviors
KW - animal models
KW - hippocampus
KW - memory
KW - phosphatase STEP
UR - http://www.scopus.com/inward/record.url?scp=85044274134&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044274134&partnerID=8YFLogxK
U2 - 10.1016/j.cub.2018.02.047
DO - 10.1016/j.cub.2018.02.047
M3 - Article
C2 - 29576474
AN - SCOPUS:85044274134
SN - 0960-9822
VL - 28
SP - 1079-1089.e4
JO - Current Biology
JF - Current Biology
IS - 7
ER -